Literature DB >> 27896552

Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.

E Jennifer Edelman1,2,3, Brent A Moore4,5, Sarah K Calabrese5,6,7, Gail Berkenblit8, Chinazo Cunningham9, Viraj Patel9, Karran Phillips10, Jeanette M Tetrault4, Minesh Shah11, David A Fiellin4,5,6, Oni Blackstock9.   

Abstract

Pre-exposure prophylaxis for HIV (PrEP) is recommended for people who inject drugs (PWID). Despite their central role in disease prevention, willingness to prescribe PrEP to PWID among primary care physicians (PCPs) is largely understudied. We conducted an online survey (April-May 2015) of members of a society for academic general internists regarding PrEP. Among 250 respondents, 74% (n = 185) of PCPs reported high willingness to prescribe PrEP to PWID. PCPs were more likely to report high willingness to prescribe PrEP to all other HIV risk groups (p's < 0.03 for all pair comparisons). Compared with PCPs delivering care to more HIV-infected clinic patients, PCPs delivering care to fewer HIV-infected patients were more likely to report low willingness to prescribe PrEP to PWID (Odds Ratio [95% CI] = 6.38 [1.48-27.47]). PCP and practice characteristics were not otherwise associated with low willingness to prescribe PrEP to PWID. Interventions to improve PCPs' willingness to prescribe PrEP to PWID are needed.

Entities:  

Keywords:  Attitude of health personnel; HIV prevention; Pre-exposure prophylaxis; Substance abuse

Mesh:

Substances:

Year:  2017        PMID: 27896552      PMCID: PMC5344709          DOI: 10.1007/s10461-016-1612-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  31 in total

1.  Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians.

Authors:  E Jennifer Edelman; An T Dinh; Brent A Moore; Richard S Schottenfeld; David A Fiellin; Lynn E Sullivan
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

2.  Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement.

Authors:  A A Artenie; D Jutras-Aswad; É Roy; G Zang; J-M Bamvita; A Lévesque; J Bruneau
Journal:  J Viral Hepat       Date:  2015-01-14       Impact factor: 3.728

3.  The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs.

Authors:  Michael Martin; Suphak Vanichseni; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Marcel E Curlin; Supawadee Na-Pompet; Anchalee Warapronmongkholkul; Somyot Kittimunkong; Roman J Gvetadze; Janet M McNicholl; Lynn A Paxton; Kachit Choopanya
Journal:  AIDS       Date:  2015-04-24       Impact factor: 4.177

4.  Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.

Authors:  Steffanie A Strathdee; Jamila K Stockman
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

5.  HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.

Authors:  Douglas Krakower; Norma Ware; Jennifer A Mitty; Kevin Maloney; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2014-09

6.  Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting.

Authors:  Daniel J Escudero; Thomas Kerr; Evan Wood; Paul Nguyen; Mark N Lurie; Omar Sued; Brandon D L Marshall
Journal:  AIDS Behav       Date:  2015-05

7.  Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users.

Authors:  A Loughlin; L Metsch; L Gardner; P Anderson-Mahoney; M Barrigan; S Strathdee
Journal:  AIDS Care       Date:  2004-05

8.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Kachit Choopanya; Michael Martin; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Praphan Kitisin; Pitinan Natrujirote; Somyot Kittimunkong; Rutt Chuachoowong; Roman J Gvetadze; Janet M McNicholl; Lynn A Paxton; Marcel E Curlin; Craig W Hendrix; Suphak Vanichseni
Journal:  Lancet       Date:  2013-06-13       Impact factor: 79.321

Review 9.  Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

Authors:  Georgina J MacArthur; Eva van Velzen; Norah Palmateer; Jo Kimber; Anastasia Pharris; Vivian Hope; Avril Taylor; Kirsty Roy; Esther Aspinall; David Goldberg; Tim Rhodes; Dagmar Hedrich; Mika Salminen; Matthew Hickman; Sharon J Hutchinson
Journal:  Int J Drug Policy       Date:  2013-08-21

Review 10.  HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.

Authors:  Daniel J Escudero; Mark N Lurie; Thomas Kerr; Chanelle J Howe; Brandon D L Marshall
Journal:  J Int AIDS Soc       Date:  2014-03-27       Impact factor: 5.396

View more
  48 in total

1.  Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.

Authors:  Rebecca B Hershow; Michelle Gonzalez; Elizabeth Costenbader; William Zule; Carol Golin; Lauren Brinkley-Rubinstein
Journal:  AIDS Educ Prev       Date:  2019-08

Review 2.  Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.

Authors:  Asher J Schranz; Jessica Barrett; Christopher B Hurt; Carlos Malvestutto; William C Miller
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

3.  Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.

Authors:  Angela R Bazzi; Dea L Biancarelli; Ellen Childs; Mari-Lynn Drainoni; Alberto Edeza; Peter Salhaney; Matthew J Mimiaga; Katie B Biello
Journal:  AIDS Patient Care STDS       Date:  2018-10-11       Impact factor: 5.078

4.  Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.

Authors:  Sarah K Calabrese; Mehrit Tekeste; Kenneth H Mayer; Manya Magnus; Douglas S Krakower; Trace S Kershaw; Adam I Eldahan; Lauren A Gaston Hawkins; Kristen Underhill; Nathan B Hansen; Joseph R Betancourt; John F Dovidio
Journal:  AIDS Patient Care STDS       Date:  2019-02       Impact factor: 5.078

5.  Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.

Authors:  Benedikt Pleuhs; Katherine G Quinn; Jennifer L Walsh; Andrew E Petroll; Steven A John
Journal:  AIDS Patient Care STDS       Date:  2020-02-28       Impact factor: 5.078

6.  A Cross-sectional Survey of Internal Medicine Resident Knowledge, Attitudes, Behaviors, and Experiences Regarding Pre-Exposure Prophylaxis for HIV Infection.

Authors:  Christopher Terndrup; Carl G Streed; Perry Tiberio; Marissa Black; John Davis; Ariella Apfel; Oni J Blackstock; E Jennifer Edelman; Gail Berkenblit
Journal:  J Gen Intern Med       Date:  2019-07       Impact factor: 5.128

7.  HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.

Authors:  Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu
Journal:  AIDS Patient Care STDS       Date:  2019-12       Impact factor: 5.078

8.  Motivations for PrEP-Related Interpersonal Communication Among Women Who Inject Drugs: A Qualitative Egocentric Network Study.

Authors:  Marisa Felsher; Emmanuel Koku; Stephen Lankenau; Kathleen Brady; Scarlett Bellamy; Alexis M Roth
Journal:  Qual Health Res       Date:  2020-09-01

9.  Prevalence and Correlates of Unhealthy Alcohol and Drug Use Among Men Who Have Sex with Men Prescribed HIV Pre-exposure Prophylaxis in Real-World Clinical Settings.

Authors:  Onyema Ogbuagu; Brandon D L Marshall; Perry Tiberio; Adedotun Ogunbajo; Lydia Barakat; Madeline Montgomery; Alexi Almonte; Tyler Wray; Emily C Williams; E Jennifer Edelman; Philip A Chan
Journal:  AIDS Behav       Date:  2019-01

10.  The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.

Authors:  Suzan M Walters; Bethany Coston; Alan Neaigus; Alexis V Rivera; Lila Starbuck; Valentina Ramirez; Kathleen H Reilly; Sarah L Braunstein
Journal:  Int J Drug Policy       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.